Drug Profile
JNJ 64152348
Alternative Names: JNJ-64152348Latest Information Update: 08 Dec 2022
Price :
$50
*
At a glance
- Originator Janssen Vaccines and Prevention B.V
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Poliomyelitis
Most Recent Events
- 08 Dec 2022 No development reported - Phase-II for Poliomyelitis (In infants, Prevention) in Philippines (IM)
- 28 Nov 2020 No recent reports of development identified for phase-I development in Poliomyelitis(Prevention) in Belgium (IM, Injection)
- 17 Oct 2019 Janssen Vaccines & Prevention completes a phase II trial in Poliomyelitis (In infants, Prevention) in Philippines (IM) (NCT03566940)